Application progress of tuberculosis interferon-γ release assay in immune checkpoint inhibitors treatment
Immune checkpoint inhibitors (ICIs) are being widely applied in the treatment of various malignancies, significantly prolonging survival and improving quality of life. However, consequent immune-related adverse events have emerged as new clinical challenges. As a high-burden country for tuberculosis...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Shanghai Chinese Clinical Medicine Press Co., Ltd.
2026-02-01
|
| Schriftenreihe: | Zhongguo Linchuang Yixue |
| Schlagworte: | |
| Online-Zugang: | https://www.c-jcm.com/article/doi/10.12025/j.issn.1008-6358.2025.20250327 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|